Medicine
Qnasl 80 mcg nasal spray
Qnasl 80 mcg nasal spray is a prescription medicine containing Beclomethasone dipropionate for nasal use, marketed by Teva Respiratory, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at temperature between 20° and 25°C (68° and 77°F), excursions are…
Key facts
- Active ingredient (INN)
- Beclomethasone dipropionate
- Brand
- Qnasl
- Strength
- 80 mcg
- Dosage form
- Nasal spray
- Route
- Nasal
- Packs
- 1 inhaler
- Marketing authorisation holder
- Teva Respiratory
- Manufacturer
- Teva Respiratory
- Origin register
- US FDA, United States
- Storage
- Store at temperature between 20° and 25°C (68° and 77°F), excursions are permitted between 15° and 30°C (59° and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A07EA07 Beclomethasone dipropionate
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 January 2019
- Identifiers
- RxCUI 1797900, 1797902, 1797920 +1DailyMed set ID 4b8d8e84-b5d2-4e56-97ec-4f72971465c5NDC 59310-410Application NDA202813
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 inhaler in 1 carton / 120 aerosol, metered in 1 inhaler | 59310-410-12 | Teva Respiratory | 2 January 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Beclomethasone dipropionate
Clinical summary
Beclomethasone dipropionate is a corticosteroid indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older. MedsAcross supplies Beclomethasone dipropionate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Beclomethasone dipropionateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- QNASL prescribing information (Teva Respiratory) · U.S. National Library of Medicine, DailyMed
Need Qnasl 80 mcg nasal spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.